APA (7th ed.) Citation

Wang, S., Shi, G., Liu, Q., Liu, G., Liu, Y., Han, Y., . . . Xie, S. (2025, September). Treatment of advanced lung adenocarcinoma with EGFR L833V/H835L compound mutations using furmonertinib: Two case reports and literature review. Frontiers in Medicine.

Chicago Style (17th ed.) Citation

Wang, Shize, Guoliang Shi, Qingyi Liu, Guangjie Liu, Yanjie Liu, Yaqing Han, Maogang Gao, Kaihong Han, and Shaonan Xie. "Treatment of Advanced Lung Adenocarcinoma with EGFR L833V/H835L Compound Mutations Using Furmonertinib: Two Case Reports and Literature Review." Frontiers in Medicine Sep. 2025.

MLA (9th ed.) Citation

Wang, Shize, et al. "Treatment of Advanced Lung Adenocarcinoma with EGFR L833V/H835L Compound Mutations Using Furmonertinib: Two Case Reports and Literature Review." Frontiers in Medicine, Sep. 2025.